SafeLM Versus LMA Classic for Airway Management During Fibroadenoma Excision
Comparison of Airway Control Effectiveness of the SafeLM Video Laryngeal Mask and the LMA Classic in Patients Undergoing General Anesthesia for Fibroadenoma Excision
This randomized controlled trial compares the airway management performance of the SafeLM video laryngeal mask with the LMA Classic in adult patients undergoing elective fibroadenoma excision under general anesthesia. Participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic. The primary outcome is oropharyngeal leak pressure. Secondary outcomes include insertion performance, ventilation parameters, hemodynamic responses, and airway-related adverse events.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
The SafeLM is a video-assisted laryngeal mask that allows visualization during placement, whereas the LMA Classic is a conventional supraglottic airway device. This study is designed to compare the clinical performance of these two devices under standardized conditions.
Adult patients scheduled for elective fibroadenoma excision under general anesthesia will be screened for eligibility. Only patients for whom both devices are considered clinically appropriate will be enrolled, thereby avoiding randomization when patient characteristics indicate a preference for a particular airway management technique. Eligible participants will be randomly assigned to airway management with either the SafeLM or the LMA Classic.
After standardized induction of general anesthesia, the assigned laryngeal mask will be inserted according to the study protocol. The primary outcome is oropharyngeal leak pressure after successful placement. Device insertion characteristics, ventilation parameters, hemodynamic responses, and airway-related adverse events will also be evaluated.
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Hung T. Tran, MD
- Номер телефона: +84367378519
- Электронная почта: thanhhungvt@gmail.com
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Female patients aged 18 years or older.
- Scheduled for elective excision of benign breast fibroadenoma under general anesthesia.
- Planned airway management with a laryngeal mask airway.
- American Society of Anesthesiologists (ASA) physical status I-II.
- Both the SafeLM and LMA Classic are considered clinically appropriate for airway management.
- Provision of written informed consent.
Exclusion Criteria:
- Increased risk of pulmonary aspiration, including inadequate preoperative fasting, full stomach, or gastrointestinal obstruction.
- Known or suspected difficult airway or other airway characteristics for which random allocation between the two study devices is considered clinically inappropriate.
- Upper airway pathology or anatomical abnormality that may interfere with laryngeal mask placement.
- Clinical or surgical indication requiring tracheal intubation rather than a laryngeal mask airway.
- Contraindication or known allergy to medications used in the standardized anesthesia protocol.
- Inability to provide informed consent.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Другой
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: SafeLM Video Laryngeal Mask
Participants randomized to this arm will receive airway management with the SafeLM video laryngeal mask during general anesthesia for elective fibroadenoma excision. The device will be inserted according to the standardized study protocol. |
The SafeLM is a video-assisted supraglottic airway device that allows visualization of the laryngeal structures during insertion and positioning. It will be used for airway management during general anesthesia according to the standardized study protocol. |
|
Активный компаратор: LMA Classic
Participants randomized to this arm will receive airway management with the LMA Classic during general anesthesia for elective fibroadenoma excision. The device will be inserted according to the standardized study protocol. |
The LMA Classic is a conventional supraglottic airway device without video guidance. It will be used for airway management during general anesthesia according to the standardized study protocol. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Oropharyngeal Leak Pressure (OLP)
Временное ограничение: Immediately after successful laryngeal mask placement, before the start of surgery
|
Oropharyngeal leak pressure will be measured after successful placement of the assigned laryngeal mask and establishment of effective ventilation. OLP will be recorded in cmH2O as the airway pressure at which an audible oropharyngeal leak is detected during a standardized leak test. |
Immediately after successful laryngeal mask placement, before the start of surgery
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
First-attempt insertion success
Временное ограничение: During initial laryngeal mask insertion
|
Proportion of participants in whom effective ventilation is achieved after the first insertion attempt of the assigned laryngeal mask. |
During initial laryngeal mask insertion
|
|
Overall insertion success
Временное ограничение: During laryngeal mask insertion, up to 3 attempts
|
Proportion of participants in whom effective ventilation is achieved with the assigned laryngeal mask within the maximum number of insertion attempts permitted by the study protocol. |
During laryngeal mask insertion, up to 3 attempts
|
|
Laryngeal mask insertion time
Временное ограничение: During laryngeal mask insertion
|
Time in seconds from introduction of the assigned laryngeal mask into the mouth until establishment of effective ventilation. |
During laryngeal mask insertion
|
|
Number of insertion attempts
Временное ограничение: During laryngeal mask insertion
|
Number of attempts required to achieve successful placement and effective ventilation with the assigned laryngeal mask. |
During laryngeal mask insertion
|
|
Need for additional airway maneuvers
Временное ограничение: During laryngeal mask insertion
|
Proportion of participants requiring additional maneuvers to achieve satisfactory placement and ventilation. |
During laryngeal mask insertion
|
|
Peak inspiratory pressure
Временное ограничение: At 5 and 30 minutes after successful laryngeal mask placement
|
Peak inspiratory airway pressure measured in cmH2O during mechanical ventilation. |
At 5 and 30 minutes after successful laryngeal mask placement
|
|
End-tidal carbon dioxide
Временное ограничение: At 5 and 30 minutes after successful laryngeal mask placement
|
End-tidal carbon dioxide (EtCO2) measured during mechanical ventilation. |
At 5 and 30 minutes after successful laryngeal mask placement
|
|
Heart Rate
Временное ограничение: At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
Heart rate will be recorded in beats per minute (bpm). |
At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
|
Blood staining on the laryngeal mask
Временное ограничение: Immediately after device removal
|
Presence of visible blood staining on the laryngeal mask after removal. |
Immediately after device removal
|
|
Postoperative sore throat
Временное ограничение: At 1 and 24 hours after surgery
|
Presence of patient-reported sore throat following general anesthesia. |
At 1 and 24 hours after surgery
|
|
Postoperative hoarseness
Временное ограничение: At 1 and 24 hours after surgery
|
Presence of patient-reported hoarseness following general anesthesia. |
At 1 and 24 hours after surgery
|
|
Airway-related adverse events
Временное ограничение: From laryngeal mask insertion through postoperative observation, assessed up to 24 hours after surgery
|
Occurrence of airway-related adverse events, including laryngospasm and clinically evident regurgitation. |
From laryngeal mask insertion through postoperative observation, assessed up to 24 hours after surgery
|
|
Arterial Pressure
Временное ограничение: At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
Arterial pressure will be recorded in mmHg. |
At baseline, immediately after successful laryngeal mask placement, and at 5 and 30 minutes after placement
|
Соавторы и исследователи
Спонсор
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Другие идентификационные номера исследования
- HMU-SAFELM-CLASSIC-2026-01
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
продукт, произведенный в США и экспортированный из США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .